| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.2M | — | -96.1% |
| R&D Expense | $39.7M | — | +21.4% |
| SG&A Expense | $20.0M | — | +36.3% |
| Operating Income | -$53.4M | — | -148.0% |
| Interest Expense | $23K | — | +2200.0% |
| Pre-tax Income | -$50.0M | — | -143.8% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$50.0M | — | -144.3% |
| EPS (Basic) | -$0.79 | — | -140.5% |
| EPS (Diluted) | -$0.79 | — | -141.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $155.7M | +84.8% | -43.4% |
| Accounts Receivable | $4.5M | -25.0% | — |
| Current Assets | $366.7M | +19.9% | -2.4% |
| Total Assets | $443.3M | +5.9% | +8.9% |
| Current Liabilities | $40.8M | -29.5% | -8.7% |
| Total Liabilities | $48.4M | -26.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$60.6M | — | -146.0% |
| Capital Expenditures | $353K | — | +132.2% |
| Investing Cash Flow | $50.7M | — | +271.9% |
| Financing Cash Flow | $84.3M | — | +6037.3% |
| Free Cash Flow | -$60.9M | — | -146.3% |
| -14.8% |
| Stockholders' Equity | $394.9M | +12.0% | +12.8% |